Loading...
Market
Will the AI system in the OpenAI and Los Alamos partnership pass clinical trials for bioscience lab applications by the end of 2024?
2
Resolution / Starting Odds
Yes • 50%
No • 50%
Official clinical trial results published in a recognized scientific journal or on the official websites of OpenAI or Los Alamos National Laboratory
Story
OpenAI Partners with Los Alamos to Study AI in Bioscience Labs Following White House Order
Jul 10, 2024, 02:06 PM
OpenAI and Los Alamos National Laboratory have announced a partnership to explore the safe use of AI in bioscientific research. This collaboration, prompted by a White House executive order, aims to study AI applications in real-world lab settings, particularly focusing on the capabilities of GPT-4o in assisting laboratory tasks. The partnership seeks to revolutionize scientific research by ensuring the safe integration of advanced AI technologies in bioscience labs. Concerns have been raised about whether these AI systems are HIPPA-compliant or have been proven by clinical trials.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Safety and Risk Mitigation • 25%
Efficiency and Performance • 25%
Ethical Considerations • 25%
Public Health Impact • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Expansion of AI in bioscience • 25%
New AI safety protocols • 25%
Collaboration with other institutions • 25%
Public outreach and education • 25%
Yes • 50%
No • 50%
Pass • 33%
Fail • 33%
Deferred • 34%
Yes • 33%
No • 33%
Unclear/Disputed • 34%